Ambu stock edges higher as investors digest latest guidance and valuation
Published on 09/20/2026 at 12:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Ambu stock (ISIN DK0060946788) recently changed hands at around DKK 65.55 on Cboe Europe as of September 18, 2026, marking a modest positive move over the past five trading days while remaining below its year-to-date level.
Ambu stock price and recent performance
According to MarketScreener, Ambu’s Cboe Europe listing showed a price of DKK 65.55 with the market closing at 18:55 local time on September 18, 2026, representing a 0.15% gain over the preceding five-day period and a 0.15% decline since the start of the year.
This level indicates that Ambu stock has been relatively stable in recent sessions, with the small five-day increase suggesting cautious optimism among investors while the negative year-to-date change underlines ongoing valuation pressure compared with its position at the beginning of 2026.
Fundamental backdrop and guidance
In the latest available reporting period, Ambu has emphasized revenue growth in its key single-use endoscopy and anesthesia product lines, alongside efforts to improve profitability through cost discipline and operational efficiencies, as highlighted in its recent investor materials on the company’s investor-relations site, according to Ambu.
For the most recent financial year and interim reporting periods within the last 24 months, Ambu has reported revenue growth compared with the prior year, supported by increased demand for single-use endoscopes and emergency care products, while also commenting on margin development and guidance ranges for the current fiscal year in its financial reports and presentations, as described by Ambu.
Analyst view, risks and valuation context
Recent analyst commentary compiled in financial portals has pointed out that Ambu’s valuation reflects both the company’s growth prospects in single-use endoscopy and the execution risks around scaling production, pricing and reimbursement, with some brokers highlighting the importance of meeting guidance targets and improving margins in upcoming quarters, as noted in overviews of broker recommendations referenced by MarketScreener.
For investors, the interplay between Ambu’s reported revenue growth, margin trends and current share price around the mid-60s DKK level is central to the investment case: the modest recent price gain versus the small year-to-date decline suggests the market is waiting for clearer signs of sustained profitability improvements and confirmation of guidance in the next set of quarterly or half-year results from Ambu.
Ambu share data and trading venue
As of September 18, 2026, Ambu stock’s reference price of DKK 65.55 on Cboe Europe provides a snapshot of the company’s market value in the European trading environment, with the year-to-date performance figure of minus 25.68% from the same source illustrating that the current level remains materially below where the shares stood at the beginning of the year, according to MarketScreener.
Ambu stock key data
- Company: Ambu A/S
- ISIN: DK0060946788
- Ticker: AMBU
- Trading venue: Cboe Europe (primary European listing)
- Price (as of September 18, 2026, 18:55): 65.55 DKK
- Sector / Industry: Health care equipment and supplies
- Index membership: Danish market indices and health care sector benchmarks
